Brief: OncoCyte Appoints Joshua Riggs As Chief Executive Officer
02/03/2023 14:20
March 2 (Reuters) - OncoCyte Corp OCX.O :
* ONCOCYTE APPOINTS JOSHUA RIGGS AS PRESIDENT AND CHIEF
EXECUTIVE
OFFICER
* JOSHUA RIGGS HAS BEEN APPOINTED AS ITS CHIEF EXECUTIVE
OFFICER
EFFECTIVE FEBRUARY 24, 2023
Source text for Eikon: ID:nGNX84Q8NV
Further company coverage: OCX.O
Recent news on Insight Molecular Diagnostics
See all newsBrief: Insight Molecular Diagnostics Enters Amendment No. 2 To Merger Agreement On Sept 15, 2026
Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Insight Molecular Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview
Insight Molecular Diagnostics Q1 loss narrows as costs drop
Brief: Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission